Who owns Enochian Biosciences Inc?
- Ticker: RENB
- CUSIP Number: 29350e104
Tip: Access positions for across all investors
Analyze quarterly positions in Enochian Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enochian Biosciences stock
Who bought or sold Enochian Biosciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 5.6M | $9.9M | 44% | Jun 2024 |
|
| BlackRock | 3.7M | $6.4M | 1063% | Jun 2024 |
|
| BlackRock | 3.6M | $1.7M | 100% | Sep 2024 |
|
| Geode Capital Management | 1.6M | $760k | -9% | Sep 2024 |
|
| State Street Corporation | 1.3M | $2.2M | 1206% | Jun 2024 |
|
| Northern Trust | 595k | $288k | 592% | Sep 2024 |
|
| Morgan Stanley | 454k | $797k | 21% | Jun 2024 |
|
| Charles Schwab Investment Management | 199k | $96k | 0% | Sep 2024 |
|
| Commonwealth Equity Services | 102k | $49k | 0% | Sep 2024 |
|
| Cantor Fitzgerald, L. P. | 100k | $48k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 94k | $46k | -25% | Sep 2024 |
|
| Jpmorgan Chase & Co | 93k | $45k | 348% | Sep 2024 |
|
| Bank of America Corporation | 88k | $43k | 236% | Sep 2024 |
|
| Barclays | 70k | $34k | 316% | Sep 2024 |
|
| New York State Common Retirement Fund | 67k | $32k | 0% | Sep 2024 |
|
| Nuveen Asset Management | 66k | $116k | 100% | Jun 2024 |
|
| Citigroup | 61k | $30k | 271% | Sep 2024 |
|
| Goldman Sachs Group | 59k | $103k | -81% | Jun 2024 |
|
| Rhumbline Advisers | 51k | $25k | 12% | Sep 2024 |
|
| Susquehanna International | 47k | $23k | 41% | Sep 2024 |
|
| Alpine Partners VI | 47k | $82k | 100% | Jun 2024 |
|
| Alliancebernstein | 38k | $66k | 100% | Jun 2024 |
|
| Toroso Investments | 33k | $57k | -12% | Jun 2024 |
|
| MSA Advisors | 25k | $44k | 0% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 24k | $11k | 100% | Sep 2024 |
|
| Invesco | 23k | $11k | -1% | Sep 2024 |
|
| JustInvest | 22k | $11k | 100% | Sep 2024 |
|
| Jane Street | 21k | $10k | -42% | Sep 2024 |
|
| Wells Fargo & Company | 18k | $8.8k | 3% | Sep 2024 |
|
| SG Americas Securities | 18k | $9.0k | 100% | Sep 2024 |
|
| Sunrise Partners Limited Partnership | 17k | $8.2k | 100% | Sep 2024 |
|
| Two Sigma Securities | 17k | $29k | 100% | Jun 2024 |
|
| William Blair $ Company | 16k | $7.8k | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 16k | $8.0k | 0% | Sep 2024 |
|
| Y-Intercept | 12k | $6.0k | 100% | Sep 2024 |
|
| Citadel Advisors | 12k | $5.7k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 11k | $5.1k | 156% | Sep 2024 |
|
| Victory Capital Management | 10k | $5.0k | -25% | Sep 2024 |
|
| Royal Bank of Canada | 5.6k | $0 | 21% | Sep 2024 |
|
| Summit Investment Advisors | 4.8k | $2.3k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.5k | $1.7k | 0% | Sep 2024 |
|
| Amalgamated Bank | 1.7k | $1.0k | 0% | Sep 2024 |
|
| Simplex Trading | 848.00 | $0 | -85% | Sep 2024 |
|
| CWM | 153.00 | $0 | 100% | Sep 2024 |
|
| Sterling Capital Management | 89.00 | $42.995900 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 81.00 | $39.001500 | 100% | Sep 2024 |
|
| CNB Bank | 15.00 | $7.000500 | 100% | Sep 2024 |
|
Who sold out of Enochian Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ExodusPoint Capital Management | Mar 2024 | 59k | $156k |
| Qube Research & Technologies | Mar 2024 | 44k | $116k |
| Balyasny Asset Management | Mar 2024 | 39k | $104k |
| Leucadia National Corporation | Mar 2024 | 32k | $85k |
| OMERS Administration Corporation | Mar 2024 | 16k | $43k |
| Squarepoint Ops | Mar 2024 | 15k | $39k |
| Dimensional Fund Advisors | Jun 2024 | 10k | $18k |
| Macquarie Group | Mar 2024 | 5.1k | $13.176800 |
| Lazard Asset Management | Jun 2024 | 105.00 | $0 |